Retatrutide

Rated 5.00 out of 5 based on 1 customer rating
(1 customer review)

Retatrutide is a research-designated synthetic peptide developed as a triple receptor agonist, engineered around three receptor-binding motifs corresponding to the GLP-1, GIP, and glucagon receptor families. Built on a modified GIP peptide backbone with a C20 fatty diacid chain for albumin binding, it carries the molecular formula C221H342N46O68, a molecular weight of approximately 4,191.7 g/mol, and CAS number 2381089-83-2. The added glucagon-receptor activity, achieved through specific amino acid substitutions, distinguishes it structurally from dual agonists. Supplied as a white to off-white lyophilized powder, soluble in water. Strictly for research purposes only — not for human or veterinary use.

Price range: $41 through $135

Buy 1 - 2
$0
Buy 3 - 5 
10%
$0
$0
Buy 6+ 
15%
$0
$0
- +

For laboratory research purposes only. Not intended for human or veterinary use, therapeutic applications, or diagnostic purposes.

Retatrutide is a synthetic peptide developed as a triple receptor agonist targeting the GLP-1, GIP, and glucagon receptors. Its structure is based on a modified peptide backbone with a C20 fatty diacid chain designed to support albumin binding and extended activity. Specific amino-acid modifications provide activity across all three receptor pathways.

Retatrutide has the molecular formula C221H342N46O68, an approximate molecular weight of 4,191.7 g/mol, and CAS No. 2381089-83-2. It is typically supplied as a white to off-white lyophilized powder and is described as soluble in water.

The compound is primarily of interest for laboratory research into metabolic signaling and the combined effects of GLP-1, GIP, and glucagon receptor activity. For research purposes only — not for human or veterinary use.

Size

5MG, 10MG, 20MG, 30MG, 50MG, 60MG

1 review for Retatrutide

  1. Rated 5 out of 5

    Siat Fahim –

    Good Products

Add a review

Your email address will not be published. Required fields are marked *

Explore More

Scroll to Top
0